Literature DB >> 3221006

Treatment of hypertensive crisis in children with nifedipine.

J Lopez-Herce1, L Albajara, P Cagigas, S Garcia, F Ruza.   

Abstract

We report 31 episodes of hypertensive crises in children, managed with sublingual nifedipine at the following dosages: 10 mg in children with body weight (BW) higher than 20 kg, 5 mg in children with BW between 10 and 20 kg, and 2.5 mg in children with BW below 10 kg. The mean initial blood pressures were 161.41 mm Hg for the systolic pressure (mSBP) and 111.25 mm Hg for the diastolic pressure (mDBP). After nifedipine, both the mSBP and the mDBP decreased, with onset of effect five minutes after dosage and maximum decrease at 60 min (mSBP 134.93 mm Hg, mDBP 79.23 mm Hg, for decreases of 16.4 and 28.7%, respectively), and this effect persisted for 180 min. Blood pressure increased again from min 240 to min 360, yet without reaching the initial levels. One case did not respond to the first dose of nifedipine and required a second one. The effect of nifedipine was more pronounced on the DBP than on the SBP, and greater reductions of both pressures were achieved in the cases with higher initial readings. No side of medication were observed in our patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3221006     DOI: 10.1007/bf00263523

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

1.  [Use of sublingual nifedipine in the hypertensive crisis].

Authors:  J J Peret Martínez; A Roca-Cusachs i Coll; J Monmany i Roca; J Nolla i Panadès
Journal:  Med Clin (Barc)       Date:  1983-10-29       Impact factor: 1.725

2.  [Use of nifedipine in the treatment of hypertensive crisis].

Authors:  A Roca-Cusachs
Journal:  Med Clin (Barc)       Date:  1984-11-24       Impact factor: 1.725

3.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

4.  Acute and chronic effects of nifedipine in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

5.  Nifedipine, a new antihypertensive with rapid action.

Authors:  M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

6.  Efficacy and safety of sublingual nifedipine in hypertensive emergencies.

Authors:  A G Ellrodt; M J Ault; M S Riedinger; G H Murata
Journal:  Am J Med       Date:  1985-10-11       Impact factor: 4.965

7.  [Normal blood pressure values in Spanish children].

Authors:  M Sánchez Bayle; M R Estepa Soto; L López Verde; A Benito; M A Hernández Lorca; M García Santiago; B Zancada
Journal:  An Esp Pediatr       Date:  1984-01

8.  Oral nifedipine for the treatment of patients with severe hypertension.

Authors:  R C Davidson; S L Bursten; P A Keeley; M A Kenny; D K Stewart
Journal:  Am J Med       Date:  1985-10-11       Impact factor: 4.965

9.  Nifedipine in hypertensive emergencies of children.

Authors:  U Dilmen; M K Cağlar; D A Senses; E Kinik
Journal:  Am J Dis Child       Date:  1983-12

Review 10.  Treatment of hypertensive urgencies and emergencies with nifedipine.

Authors:  M C Houston
Journal:  Am Heart J       Date:  1986-05       Impact factor: 4.749

View more
  5 in total

1.  Dosage of nifedipine in hypertensive crises of infants and children.

Authors:  J Lopez-Herce; P Dorao; P de la Oliva; M A Delgado; M C Martinez; F Ruza
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

Review 2.  A review of calcium channel antagonists in the treatment of pediatric hypertension.

Authors:  Shobha Sahney
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 3.  Comparative tolerability profile of hypertensive crisis treatments.

Authors:  E Grossman; A N Ironi; F H Messerli
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

4.  The safety and use of short-acting nifedipine in hospitalized hypertensive children.

Authors:  Verna Yiu; Elaine Orrbine; Rhonda J Rosychuk; Peter MacLaine; Paul Goodyer; Colette Girardin; Manjula Gowrishankar; Malcolm Ogborn; Julian Midgley; Guido Filler; Frances Harley
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714

Review 5.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.